Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Drug GMP and CMC Updates In Brief: Guidance Advances on Several Fronts

Oct 17 2022

• By Bowman Cox

guidance advances — fda guidance advances • Source: Shutterstock

Related Content

US FDA Explains How It Is Embracing Remote Assessments Post-Pandemic

Jul 22 2022

US FDA Gives Industry An Extension On Nitrosamine Risk Assessments

Feb 26 2021

Remote Site Visits Will Help US FDA Keep Reviews On Track During Remainder Of Pandemic

Apr 15 2021

US FDA Expectations For Removing Nitrosamines From All APIs, Drug Products

Sep 02 2020

Differences Put Aside As ICH Finalizes Guide On Post Approval Changes

Dec 02 2019

Generic Firms Fear 'New Lifecycle Management Tool' From FDA Pill Size Guidance

Jun 22 2015

Regulatory Updates In Brief

Apr 28 2016

Additional Topics

United States Manufacturing Quality Compliance Drug Approval Standards Ingredients BioPharmaceutical

More from Manufacturing

More from Compliance

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.